Forbion

Boston, Massachusetts

Firm Location:Boston, Massachusetts • Munich, Germany • Amsterdam, Netherlands • Netherlands • Denmark • Copenhagen, Denmark • United Kingdom • Naarden, Netherlands

Investor Firms That Co-Invest with Forbion

General Atlantic Cambridge Innovation Capital F-Prime Capital Partners High-Tech Gründerfonds RA Capital Management Novartis Venture Fund Novo Holdings Atlas Venture ARCH Venture Partners Alta Partners Third Rock Ventures Ysios Capital Founders Fund Pfizer Venture Investments Arcus Ventures New Enterprise Associates (NEA)Nextech Invest Longwood Fund Sanofi Ventures Seventure Partners Pontifax Venture Capital Sofinnova Investments Andera Partners 4See Ventures BGV (BioGeneration Ventures)Advent Life Sciences Ascendant BioCapital Access Industries INKEF Capital U.S. Venture Partners (USVP)Red Tree Venture Capital Versant Ventures Polaris Partners 5am Ventures OrbiMed Seroba Life Sciences Sofinnova Partners Self-employed Aglaia Oncology Funds AgeChem Polaris Venture Partners Hotmail RiverVest Venture Partners RTW Investments, LP Alex & Thiago SpectraWAVE, Inc.EQT Group Financial Services, Financial Technology, and Business Services Nan Fung Life Sciences Life Sciences Partners

Forbion Team

Philip Astley-Sparke

Forbion·Venture Partner

Sweet spot: $1.5M

Range: $100K - $5.0M

Investors in Boston (MA)

to see your intro paths to Philip

Juliette Audet

Forbion·Partner

Sweet spot: $1.5M

Range: $100K - $5.0M

Investors in Netherlands

Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A)

to see your intro paths to Juliette

Marco Boorsma

Forbion·General Partner

Sweet spot: $1.5M

Range: $100K - $5.0M

Investors in Naarden (Netherlands), Investors in Amsterdam (Netherlands)

Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Manufacturing (Seed), Investors in Manufacturing (Series A), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in Diagnostics (Seed), Investors in Diagnostics (Series A)

to see your intro paths to Marco

Jasper Bos

Forbion·General Partner

Sweet spot: $1.5M

Range: $100K - $5.0M

Investors in Amsterdam (Netherlands)

Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series A), Investors in Health IT (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)

to see your intro paths to Jasper

Antoine Boulanger Piette

Forbion·Principal

Sweet spot: $1.5M

Range: $100K - $5.0M

Investors in Amsterdam (Netherlands)

Investors in BioTech (Seed), Investors in Health IT (Series A), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Health IT (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)

to see your intro paths to Antoine

Audrey Cacaly

Forbion·Principal

Sweet spot: $1.5M

Range: $100K - $5.0M

Investors in Netherlands

Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series A), Investors in Health IT (Series A), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Health IT (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)

to see your intro paths to Audrey

Dmitrij Hristodorov

Forbion·General Partner

Sweet spot: $1.5M

Range: $100K - $5.0M

Investors in Munich (Germany)

to see your intro paths to Dmitrij

Wouter Joustra

Forbion·General Partner

Sweet spot: $1.5M

Range: $100K - $5.0M

Investors in Amsterdam (Netherlands)

Investors in BioTech (Series B)

to see your intro paths to Wouter

Dirk Kersten

Forbion·Managing Partner

Sweet spot: $1.5M

Range: $100K - $5.0M

Investors in Amsterdam (Netherlands)

Investors in Consumer Health (Series A), Investors in Consumer Health (Seed), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series A), Investors in Health IT (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)

to see your intro paths to Dirk

Nanna Luneborg

Forbion·General Partner

Sweet spot: $1.5M

Range: $100K - $5.0M

Investors in Denmark

Investors in BioTech (Series B), Investors in Health & Hospital Services (Series B)

to see your intro paths to Nanna

Geert-Jan Mulder

Forbion·Managing Partner

Sweet spot: $1.5M

Range: $100K - $5.0M

Investors in Naarden (Netherlands)

Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series A), Investors in Diagnostics (Seed), Investors in Diagnostics (Series A), Investors in Health IT (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)

to see your intro paths to Geert-Jan

Holger Reithinger

Forbion·Advisor

Sweet spot: $1.5M

Range: $100K - $5.0M

Investors in Munich (Germany)

Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Medical Devices (Series A), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series A), Investors in Diagnostics (Seed), Investors in Diagnostics (Series A), Investors in Health IT (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)

to see your intro paths to Holger

Sander Slootweg

Forbion·Managing Partner

Sweet spot: $1.5M

Range: $100K - $5.0M

Investors in Netherlands

to see your intro paths to Sander

Marc-Olivier Turgeon

Forbion·Senior Associate

Sweet spot: $1.5M

Range: $100K - $5.0M

Investors in Amsterdam (Netherlands)

Investors in BioTech (Seed), Investors in BioTech (Series A)

to see your intro paths to Marc-Olivier

Martien van Osch

Forbion·Managing Partner

Sweet spot: $1.5M

Range: $100K - $5.0M

Investors in Amsterdam (Netherlands)

to see your intro paths to Martien

Alice Vickers

Forbion·Advisor

Sweet spot: $1.5M

Range: $100K - $5.0M

Investors in United Kingdom

to see your intro paths to Alice

Matthias Vinther

Forbion·Partner

Sweet spot: $1.5M

Range: $100K - $5.0M

Investors in Copenhagen (Denmark)

Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series B), Investors in Medical Devices (Series B), Investors in Medical Devices (Series A), Investors in Pharmaceuticals (Series B), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in Diagnostics (Series B), Investors in Diagnostics (Seed), Investors in Diagnostics (Series A), Investors in Pharmaceuticals (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in BioTech (Pre-seed)

to see your intro paths to Matthias